Showing codes 25021-219-20 Decitabine — 25021-249-51 Cyclophosphamide

25021-219-20 - Decitabine
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-219-20) / 20 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-221-60 - Melphalan Hydrochloride
Firm: Sagent Pharmaceuticals
Package Description: 1 KIT in 1 CARTON (25021-221-60) * 10 mL in 1 VIAL (25021-220-10) * 10 mL in 1 VIAL (25021-210-15)
Usage type: INTRAVENOUS
HTML  TXT

25021-222-01 - Docetaxel
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-222-01) > 1 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-222-04 - Docetaxel
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-222-04) > 4 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-222-07 - Docetaxel
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-222-07) > 7 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-223-20 - Cytarabine
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-223-20) / 20 mL in 1 VIAL
Usage type: INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS
HTML  TXT

25021-226-10 - Arsenic Trioxide
Firm: Sagent Pharmaceuticals
Package Description: 10 VIAL in 1 CARTON (25021-226-10) / 10 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-227-06 - Arsenic Trioxide
Firm: Sagent Pharmaceuticals
Package Description: 10 VIAL in 1 CARTON (25021-227-06) / 6 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-229-05 - Cytarabine
Firm: Sagent Pharmaceuticals
Package Description: 5 VIAL in 1 CARTON (25021-229-05) / 5 mL in 1 VIAL
Usage type: INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS
HTML  TXT

25021-230-02 - Irinotecan Hydrochloride
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-230-02) / 2 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-230-05 - Irinotecan Hydrochloride
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-230-05) / 5 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-231-20 - Decitabine
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-231-20) / 10 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-233-10 - Oxaliplatin
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-233-10) / 10 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-233-20 - Oxaliplatin
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-233-20) / 20 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-234-10 - Gemcitabine
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-234-10) / 5 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-235-50 - Gemcitabine
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-235-50) / 25 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-235-51 - Gemcitabine
Firm: Sagent Pharmaceuticals
Package Description: 10 VIAL in 1 CARTON (25021-235-51) / 25 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-236-04 - Topotecan
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-236-04) > 4 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-237-06 - Fludarabine Phosphate
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-237-06) > 2 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-239-05 - Gemcitabine
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-239-05) > 5.26 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-239-26 - Gemcitabine
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-239-26) > 26.3 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-239-52 - Gemcitabine
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-239-52) > 52.6 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-241-10 - Busulfan
Firm: Sagent Pharmaceuticals
Package Description: 8 VIAL in 1 CARTON (25021-241-10) > 10 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-242-02 - Fludarabine Phosphate
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-242-02) / 2 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-244-10 - Bortezomib
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-244-10) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
Usage type: INTRAVENOUS; SUBCUTANEOUS
HTML  TXT

25021-245-01 - Docetaxel
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-245-01) / 1 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-245-04 - Docetaxel
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-245-04) / 4 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-246-02 - Thiotepa
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-246-02) > 1.5 mL in 1 VIAL
Usage type: INTRACAVITARY; INTRAVENOUS; INTRAVESICAL
HTML  TXT

25021-247-50 - Cyclophosphamide
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-247-50) / 25 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-248-51 - Cyclophosphamide
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-248-51) / 50 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT

25021-249-51 - Cyclophosphamide
Firm: Sagent Pharmaceuticals
Package Description: 1 VIAL in 1 CARTON (25021-249-51) / 100 mL in 1 VIAL
Usage type: INTRAVENOUS
HTML  TXT